Abstract
Purpose
To evaluate the functional and oncologic outcomes of adjuvant (chemo)radiation [(C)RT] after open partial horizontal laryngectomies (OPHLs).
Methods
Multicenter retrospective evaluation of 130 patients (116 males, 14 females) submitted between 1995 and 2017 to OPHL Types II and III for laryngeal cancer and receiving adjuvant (C)RT for one or more of the following risk factors at histopathologic examination of the surgical specimen: pT4a and/or > pN2a categories, close/positive resection margins, or presence of both perineural (PNI) and lympho-vascular invasion (LVI). The primary study endpoints were evaluation of the presence of tracheostomy and/or gastrostomy at last follow-up, and calculation of laryngo-esophageal dysfunction-free survival (LEDFS).
Results
Mean age of the study cohort was 60.8 ± 8.9 years (median, 62; interquartile range [IQR], 13). Mean follow-up was 50.7 ± 39.4 months (range 24–188; median, 38; IQR, 51). Adjuvant therapy consisted of CRT in 53 (41%) patients, and RT alone in 77 (59%). Five-year LEDFS was 85%. Overall survival was 71.5%, while 13% of patients remained tracheostomy- and 3% gastrostomy-dependent at the last follow-up. The only significant variable in predicting survival (p = 0.020) was tracheostomy dependence: it was maintained in 7.5% of subjects after OPHL Type II and in 34% of those submitted to OHPL Type III (p < 0.001).
Conclusions
In selected patients affected by advanced laryngeal cancer, OPHLs Type II and III have a relatively good laryngeal safety profile and provide favorable oncologic outcomes even in case of need for adjuvant (C)RT.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author, RL, upon reasonable request.
References
Forastiere A, Lewin JS, Nathan CA et al (2018) Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 36:1143–1169
Majer E, Rieder W (1959) Technique de laryngectomiepermettant de conserver la perméabilitérespiratoire (la crico-hyoidopexie). Ann OtolaryngolChirCervicofac 76:677–681
Labayle J, Bismuth R (1971) Laryngectomietotale avec reconstruction. Ann OtolaryngolChirCervicofac 88:219–228
Pique JJ, Desaulty A, Decroix G (1974) Crico-hyoido-épiglottopexie. Technique opératoire et résultatsfonctionnels. Ann OtolaryngolChirCervicofac 91:681–689
Rizzotto G, Succo G, Lucioni M, Pazzaia T (2006) Subtotal laryngectomy with tracheoioidopexy: a possible alternative to total laryngectomy. Laryngoscope 116:1907–1917
Succo G, Peretti G, Piazza C et al (2014) Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European Laryngological Society. Eur Arch Otorhinolaryngol 271:2489–2496
Riga M, Chelis L, Danielides V, Vogiatzaki T, Pantazis T, Pantazis D (2016) Systematic review on T3 laryngeal squamous cell carcinoma: still far from a consensus on the optimal organ preserving treatment. Eur J Surg Oncol 43:20–31
Succo G, Crosetti E, Bertolin A et al (2015) Benefits and drawbacks of open partial horizontal laryngectomies, part B: intermediate and selected advanced stage laryngeal carcinoma. Head Neck 33:649–657
Strojan P, Haigentz M Jr, Bradford CR et al (2013) Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal carcinoma. Oral Oncol 49:283–286
Marchi F, Filauro M, Missale, et al (2019) A Multidisciplinary team guided approach to the management of cT3 laryngeal cancer: a retrospective analysis of 104 cases. Cancers (Basel) 11(5):717
Maroldi R, Ravanelli R, Farina D (2014) Magnetic resonance for laryngeal cancer. CurrOpinOtolaryngol Head Neck Surg 22(2):131–139
Piazza C, Cocco D, Del Bon F, Mangili S, Nicolai P, Peretti G (2011) Narrow band imaging and high definition television in the endoscopic evaluation of upper aero-digestive tract cancer. Acta Otorhinolaryngol Ital 31:70–75
Colevas AD, Yom SS, Pfister DG et al (2018) NCCN Guidelines® insights head and neck cancers featured updates to the NCCN Guidelines. J Natl ComprCancNetw 16:479–490
Brierley JD, Gospodarowicz MK, Wittekind C et al (2017) TNM classification of malignant tumours, 8th edn. Wiley Blackwell, Oxford
Simo R, Bradley P, Chevalier D et al (2014) European Laryngological Society: ELS recommendations for the follow up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol 271:2469–2479
Marchi F, Piazza C, Ravanelli M et al (2017) Role of imaging in the follow-up of T2–T3 glottic cancer treated by transoral laser microsurgery. Eur Arch Otorhinolaryngol 274(10):3679–3686
Laccourreye O, Hans S, Borzog-Grayeli A, Maulard-Durdux C, Brasnu D, Housset M (2000) Complications of postoperative radiation therapy after partial laryngectomy in supraglottic cancer: a long term evaluation. Otolaryngol Head Neck Surg 122:752–757
Alterio D, Ansarin M, Jereczek-Fossa BA et al (2013) What is the price of functional surgical organ preservation in local-regionally advanced supraglottic cancer? Long term outcome for partial laryngectomy followed by radiotherapy in 32 patients. Tumori 99:667–675
Buglione M, Pedretti S, Costa L et al (2015) Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease. Radiol Med 120(11):1071–1077
Costa L, Pedretti S, Foscarini F et al (2016) Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease. Radiol Med 121(1):70–79
Guzzo M, Ferraro L, Rezzonico S et al (2011) Open organ preservation surgery of the larynx: experience of IstitutoNazionaleTumori of Milan. Head Neck 33(5):673–678
Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with advanced laryngeal cancer. J Clin Oncol 31:845–852
Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098
Del Bon F, Piazza C, Lancini D, et al (2019) Open partial horizontal laryngectomies for T3-T4 laryngeal cancer: Prognostic impact of anterior vs. posterior laryngeal compartmentalization. Cancers (Basel) 11(3): E289
Dyckhoff G, Plinkert PK, Ramroth R (2017) A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients. BMC Cancer 17:609
Al-Gilani M, Skillington SA, Kallogjeri D, Haughey B, Piccirillo JF (2016) Surgical vs. non surgical treatment modalities for T3 glottic squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 142:940–946
Al-Mamgani A, Navran A, Walraven I, Schreuder WH, Tesselaar MET, Klop WMC (2019) Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth? Eur Arch Otorhinolaryngol 276(2):575–583
Beitler JJ, Ridge JA, Vermorken JB et al (2018) T4 laryngeal cancer with good function: should we be reluctant to treat without surgery? Int J Radiat Oncol Biol Phys 102(5):1400–1403
Mendenhall WM, Parsons JT, Mancuso AA, Pameijer FJ, Stringer SP, Cassisi NJ (1997) Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx. J Clin Oncol 15:2394–2402
MacKenzie R, Franssen E, Balogh J, Birt D, Gilbert R (1998) The prognostic significance of tracheostomy in carcinoma of the larynx treated with radiotherapy and surgery for salvage. Int J Radiat Oncol Biol Phys 41:43–51
Giacalone NJ, Qureshi MM, Mak KS et al (2017) Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer. Laryngoscope 128:831–840
Pellini R, Mercante G, Marchese C, Terenzi V, Sperduti I, Manciocco V, Ruscito P, Cristalli G, Marchesi P, Pichi B, Spriano G (2013) Predictive factors for postoperative wound complications after neck dissection. Acta Otorhinolaryngol Ital 33(1):16–22
Li M, Zhang T, Tan B, Yu M, Zhang B (2019) Role of postoperative adjuvant radiotherapy for locally advanced laryngeal cancer: a meta-analysis. Acta Otolaryngol 139:172–177
Chen MM, Colevas AD, Megwalu U, Divi V (2018) Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age. Oral Oncol 84:71–75
Sanabria A, Carvalho A, Vartanian J, Magrin J, Ikeda M, Kowalski L (2007) Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope 117:835–840
Kanwar A, Hutcheson KA, Ghosh A et al (2018) Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck 40:2060–2069
Acknowledgments
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Funding
Authors declare that they didn't receive any financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests
Ethics approval
The study was approved by the local Ethics Committee of the first author's (LM) affiliation.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Muscatello, L., Piazza, C., Peretti, G. et al. Open partial horizontal laryngectomy and adjuvant (chemo)radiotherapy for laryngeal squamous cell carcinoma: results from a multicenter Italian experience. Eur Arch Otorhinolaryngol 278, 4059–4065 (2021). https://doi.org/10.1007/s00405-021-06651-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-06651-6